Jeremy Grantham's SNY Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 98,171 shares of Sanofi (SNY) worth $4.76 M, representing 0.01% of the portfolio. First purchased in 2018-Q1, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in SNY, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2019, adding 92,200 shares. Largest reduction occurred in Q3 2020, reducing 175,600 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Sanofi (SNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sanofi (SNY) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +13,007 | Add 15.27% | 98,171 | $48.46 |
| Q3 2025 | +42,491 | Add 99.57% | 85,164 | $47.20 |
| Q2 2025 | +6,865 | Add 19.17% | 42,673 | $48.31 |
| Q1 2025 | +17,019 | Add 90.58% | 35,808 | $55.46 |
| Q4 2024 | +18,789 | New Buy | 18,789 | $48.23 |
| Q1 2021 | -14,100 | Sold Out | 0 | $0.00 |
| Q4 2020 | -111,642 | Reduce 88.79% | 14,100 | $48.58 |
| Q3 2020 | -175,600 | Reduce 58.27% | 125,742 | $50.17 |
| Q2 2020 | -125,000 | Reduce 29.32% | 301,342 | $51.05 |
| Q1 2020 | -99,200 | Reduce 18.88% | 426,342 | $43.72 |
| Q4 2019 | -53,400 | Reduce 9.22% | 525,542 | $50.20 |
| Q3 2019 | -33,700 | Reduce 5.50% | 578,942 | $46.33 |
| Q2 2019 | +92,200 | Add 17.72% | 612,642 | $43.27 |
| Q1 2019 | -7,200 | Reduce 1.36% | 520,442 | $44.28 |
| Q4 2018 | -4,000 | Reduce 0.75% | 527,642 | $43.41 |
| Q3 2018 | +77,714 | Add 17.12% | 531,642 | $44.67 |
| Q2 2018 | -13,772 | Reduce 2.94% | 453,928 | $40.01 |
| Q1 2018 | +467,700 | New Buy | 467,700 | $40.08 |
Jeremy Grantham's Sanofi Investment FAQs
Jeremy Grantham first purchased Sanofi (SNY) in Q1 2018, acquiring 467,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Sanofi (SNY) for 18 quarters since Q1 2018.
Jeremy Grantham's largest addition to Sanofi (SNY) was in Q1 2018, adding 467,700 shares worth $18.74 M.
According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 98,171 shares of Sanofi (SNY), valued at approximately $4.76 M.
As of the Q4 2025 filing, Sanofi (SNY) represents approximately 0.01% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Sanofi (SNY) was 612,642 shares, as reported at the end of Q2 2019.